• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉旁路移植术中不完全血运重建的预后影响:残余SYNTAX评分、磁共振成像、心肌损伤与心血管事件之间的关联

Prognostic impact of incomplete revascularization in coronary artery bypass grafting: Association between residual SYNTAX score, magnetic resonance imaging, myocardial injury, and cardiovascular events.

作者信息

de Azevedo Diogo Freitas Cardoso, Hueb Whady, Lima Eduardo Gomes, Rezende Paulo Cury, Nomura Cesar Higa, Franchini Ramires José Antonio, Kalil Filho Roberto

机构信息

Department of Clinical Cardiology, Heart Institute (InCor) University of São Paulo, São Paulo, Brazil.

出版信息

Medicine (Baltimore). 2025 May 30;104(22):e42478. doi: 10.1097/MD.0000000000042478.

DOI:10.1097/MD.0000000000042478
PMID:40441689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12129534/
Abstract

Cardiac biomarkers are frequently released after revascularization. Incomplete revascularization may be a potential mechanism of action. This study aimed to investigate the relationship between the completeness of revascularization, quantified by the residual SYNTAX score (rSS), and myocardial injury, infarction, and cardiac events after coronary artery bypass grafting. This study included patients with stable coronary artery disease who underwent surgery. Troponin levels, cardiac magnetic resonance, and late gadolinium enhancement were assessed before and after the procedure. The baseline SYNTAX score was determined from the angiograms, and the rSS was measured based on the operative report for each patient after the procedure. Of the 136 surgical patients studied, no significant correlations were found between the rSS and median peak troponin level (R = 0.06, P = .47). The rSS was not a predictor of myocardial infarction, as assessed by late gadolinium enhancement (odds ratio [OR] 0.96, 95% confidence interval [CI] 0.86-1.03; P = .51) and release of troponin higher than the median (OR 1.00, 95% CI 0.92-1.08; P = .93). After multivariate analysis in a model including variables, only cardiopulmonary bypass time was a significant predictor of troponin peak release, which was higher than the median (OR 1.01, 95% CI 1.002-1.019; P = .01). During the 5-year follow-up, the incomplete revascularization group had more major cardiovascular events than the complete revascularization group (rSS = 0) (P log-rank = .006, adjusted hazard ratio = 11.32; P = .001). Myocardial injury and infarction were not significantly associated with the completeness of revascularization. However, the rSS had a prognostic impact during follow-up for cardiovascular events.

摘要

心脏生物标志物常在血运重建后释放。不完全血运重建可能是一种潜在作用机制。本研究旨在探讨以残余SYNTAX评分(rSS)量化的血运重建完整性与冠状动脉旁路移植术后心肌损伤、梗死及心脏事件之间的关系。本研究纳入了接受手术的稳定型冠状动脉疾病患者。在手术前后评估肌钙蛋白水平、心脏磁共振成像及延迟钆增强。基线SYNTAX评分由血管造影确定,rSS根据术后每位患者的手术报告测量。在136例接受手术的患者中,未发现rSS与肌钙蛋白峰值中位数水平之间存在显著相关性(R = 0.06,P = 0.47)。通过延迟钆增强评估(优势比[OR] 0.96,95%置信区间[CI] 0.86 - 1.03;P = 0.51)以及肌钙蛋白释放高于中位数(OR 1.00,95% CI 0.92 - 1.08;P = 0.93),rSS并非心肌梗死的预测指标。在包含多个变量的模型中进行多因素分析后,仅体外循环时间是肌钙蛋白峰值释放高于中位数的显著预测指标(OR 1.01,95% CI 1.002 - 1.019;P = 0.01)。在5年随访期间,不完全血运重建组比完全血运重建组(rSS = 0)有更多的主要心血管事件(P对数秩检验 = 0.006,调整后风险比 = 11.32;P = 0.001)。心肌损伤和梗死与血运重建的完整性无显著关联。然而,rSS在心血管事件随访期间具有预后影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a9c/12129534/dd96c5ffb6f9/medi-104-e42478-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a9c/12129534/3d990a879f74/medi-104-e42478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a9c/12129534/3922a662a7ce/medi-104-e42478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a9c/12129534/dd96c5ffb6f9/medi-104-e42478-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a9c/12129534/3d990a879f74/medi-104-e42478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a9c/12129534/3922a662a7ce/medi-104-e42478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a9c/12129534/dd96c5ffb6f9/medi-104-e42478-g003.jpg

相似文献

1
Prognostic impact of incomplete revascularization in coronary artery bypass grafting: Association between residual SYNTAX score, magnetic resonance imaging, myocardial injury, and cardiovascular events.冠状动脉旁路移植术中不完全血运重建的预后影响:残余SYNTAX评分、磁共振成像、心肌损伤与心血管事件之间的关联
Medicine (Baltimore). 2025 May 30;104(22):e42478. doi: 10.1097/MD.0000000000042478.
2
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
3
Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).用于冠状动脉搭桥术(伴或不伴瓣膜手术)的远程缺血预处理
Cochrane Database Syst Rev. 2017 May 5;5(5):CD011719. doi: 10.1002/14651858.CD011719.pub3.
4
Psychological interventions for coronary heart disease.冠心病的心理干预措施。
Cochrane Database Syst Rev. 2017 Apr 28;4(4):CD002902. doi: 10.1002/14651858.CD002902.pub4.
5
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率:一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
6
FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes.糖尿病患者中,基于血流储备分数(FFR)指导的经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较
JAMA Cardiol. 2025 Jun 1;10(6):603-608. doi: 10.1001/jamacardio.2025.0095.
7
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
8
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
9
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
10
Comparison of hybrid coronary revascularization versus conventional Coronary Artery Bypass surgery in patients with multi-vessel coronary artery disease in a real-world setting: In-hospital outcomes and medium-term follow-up: COHOS study.真实世界中多支冠状动脉疾病患者杂交冠状动脉血运重建与传统冠状动脉搭桥手术的比较:住院结局及中期随访:COHOS研究
Indian Heart J. 2025 Mar-Apr;77(2):98-104. doi: 10.1016/j.ihj.2025.03.002. Epub 2025 Mar 5.

本文引用的文献

1
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial.缺血性心室功能障碍患者血运重建或药物治疗的存活率和结局:REVIVED-BCIS2 试验的预先设定的二次分析。
JAMA Cardiol. 2023 Dec 1;8(12):1154-1161. doi: 10.1001/jamacardio.2023.3803.
2
Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease: A Systematic Review.多支冠状动脉疾病急性冠脉综合征的完全经皮冠状动脉血运重建:一项系统评价
JACC Cardiovasc Interv. 2023 Oct 9;16(19):2347-2364. doi: 10.1016/j.jcin.2023.07.043.
3
Impact of Complete Revascularization in the ISCHEMIA Trial.
ISCHEMIA 试验中的完全血运重建的影响。
J Am Coll Cardiol. 2023 Sep 19;82(12):1175-1188. doi: 10.1016/j.jacc.2023.06.015. Epub 2023 Jul 17.
4
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021年美国心脏病学会/美国心脏协会/心血管造影和介入学会冠状动脉血运重建指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 Jan 18;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038. Epub 2021 Dec 9.
5
Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study.三血管病变或左主干病变患者完全血运重建后十年全因死亡情况:来自 SYNTAX 扩展生存研究的结果。
Circulation. 2021 Jul 13;144(2):96-109. doi: 10.1161/CIRCULATIONAHA.120.046289. Epub 2021 May 20.
6
Long-term prognostic value of late gadolinium enhancement and periprocedural myocardial infarction after uncomplicated revascularization: MASS-V follow-up.单纯血运重建后晚期钆增强和围术期心肌梗死的长期预后价值:MASS-V 随访。
Eur Heart J Cardiovasc Imaging. 2022 Jan 24;23(2):255-265. doi: 10.1093/ehjci/jeaa328.
7
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗三血管病变或左主干病变患者:多中心随机对照 SYNTAX 试验 10 年随访结果。
Lancet. 2019 Oct 12;394(10206):1325-1334. doi: 10.1016/S0140-6736(19)31997-X. Epub 2019 Sep 2.
8
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur J Cardiothorac Surg. 2019 Jan 1;55(1):4-90. doi: 10.1093/ejcts/ezy289.
9
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义(2018年)。
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25.
10
Residual SYNTAX score following coronary artery bypass grafting.冠状动脉搭桥术后的残余SYNTAX评分
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):547-553. doi: 10.1093/ejcts/ezw356.